ACRO BIOMEDICAL CO., LTD. (ACBM) Return on equity 2017–2022
ACRO BIOMEDICAL CO., LTD. (ACBM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-3263.2%FY2022 · since FY2017: -0.4% → -3263.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -3263.2% | -2067.4 pp |
| FY2021 | -1195.9% | -1178.7 pp |
| FY2020 | -17.1% | +29.4 pp |
| FY2019 | -46.6% | -80.3 pp |
| FY2018 | 33.8% | +34.2 pp |
| FY2017 | -0.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice